CMS to overhaul Part B drug purchasing

CMS is moving forward with plans to overhaul the way Medicare purchases infused and injected drugs that are administered under a physician’s supervision. It has requested public

Read the full 275 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE